论文部分内容阅读
目的:观察降纤酶、低分子肝素与尼莫地平合用治疗急性脑梗塞的疗效。方法:将58例急性脑梗塞患者随机分为对照组28例,静点低分子右旋糖酐、川芎嗪、脑复康;治疗组30例,静点降纤酶、尼莫地平,皮下注射低分子肝素。结果:治疗组有效+显效26例,总有效率86.6％(26/30);对照组有效+显效18例,总有效率61.4％(18/28);经X~2检验,P<0.05。结论:用降纤酶、低分子肝素与尼莫地平合用治疗急性脑梗塞比单用扩血管药有显著疗效。
Objective: To observe the effect of defibrase, low molecular weight heparin and nimodipine in the treatment of acute cerebral infarction. Methods: A total of 58 patients with acute cerebral infarction were randomly divided into control group (n = 28), low molecular weight dextran, ligustrazine and naofukang. The treatment group (n = 30), defibrase, nimodipine and subcutaneous injection of low molecular weight heparin . Results: The effective rate of the treatment group was 26 cases, the total effective rate was 86.6% (26/30). The effective rate of the control group was 18 cases (18/28). The effective rate was 61.4% (18/28). Conclusion: The combination of defibrase, low molecular weight heparin and nimodipine is more effective than single vasodilator in the treatment of acute cerebral infarction.